
Paul A. Hamlin, MD
Medical Oncologist
Titles
Medical Director, David H. Koch Center for Cancer Care
Clinical Expertise
Diffuse Large B-Cell Lymphoma in the Elderly; Antibody Drug Conjugates; Non-Hodgkin Lymphoma; Hodgkin's Disease; Mantle Cell Lymphoma; Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Hamlin accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type:
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type:
In Network Coverage Type(s): PPO, HMO
Payor Type:
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type:
In Network Coverage Type(s): HMO
Payor Type:
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type:
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type:
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type:
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type:
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Contact and Location
- 646-608-3706 Office Phone
- Speaks English

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, SUNY Health Science Center at Brooklyn
Residencies
Internal Medicine - New York University Medical Center
Fellowships
Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
Internal Medicine; Medical Oncology
I am a board-certified medical oncologist and a member of the MSK Lymphoma Service. My colleagues and I work to ensure a world-class collaborative environment, bringing the medical expertise, access to cutting-edge clinical research, and specialized cancer care to our patients.
Read more
I have specialized in the care of patients with Hodgkin’s disease and non-Hodgkin lymphoma (NHL) for more than a decade as an integral member of the Lymphoma Service in the Division of Hematologic Oncology. I have served as the Director of our outpatient lymphoma clinics at MSK’s main location in Manhattan and continue to lead our innovation efforts at our 64th Street location.
My clinical research interests have focused on developing novel therapies and dedicated treatment programs for older patients with lymphoma, addressing the complex interplay between aging and a cancer diagnosis. As part of a multidisciplinary MSK team that cares for patients age 65 and older, I have worked to develop new treatment strategies for older patients with diffuse large B-cell, mantle cell, and Hodgkin lymphoma, as well as patients with chronic lymphocytic leukemia/small lymphocytic leukemia. Ongoing research efforts are developing new screening tools to identify patients at increased risk for treatment side effects and clinical trials specifically aimed at addressing the needs of the older patient population. We have as our shared goal the development of effective risk-adapted therapies to minimize the side effects of treatments while maximizing their effectiveness.
As a clinical researcher, I have been the principle investigator (PI) or co-PI of more than 30 clinical trials. My work continues to explore novel biologic and immunotherapeutic agents for the treatment of both NHL and Hodgkins, with phase I and II trials focused on new antibody combinations, antibody drug conjugates, immunotoxins, and small molecule inhibitors.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Hamlin
- A Phase I/II Study of Mosunetuzumab in Combination with Polatuzumab Vedotin in Older People with Untreated Diffuse Large B-Cell Lymphoma
- A Phase III Study of Acalabrutinib plus R-CHOP Therapy in Patients 65 and Younger with Previously Untreated Diffuse Large B-Cell Lymphoma
- Clinical Trials Co-Investigated by Dr. Hamlin
- A Phase II/III Study of CC-486 (Oral Azacitidine) plus Standard Therapy in Older Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
- A Pilot Study Assessing the Effects of CAR T-Cell Therapy in Elderly Patients Treated for Lymphoma

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Hamlin’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Paul A. Hamlin discloses the following relationships and financial interests:
-
Calithera
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].